Enovix Corporation vs Vital Farms Inc — how do they compare? Enovix Corporation trades at $2.46 (market cap $549.72M), while Vital Farms Inc trades at $9.38 (market cap $405.27M). The key difference: Enovix Corporation is the larger of the two by market cap, and Enovix Corporation is more actively traded (6,635,687 versus 1,810,837). Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Vital Farms Inc for 14 Days on average.
| ENVX | VITL | |
|---|---|---|
Market Cap | $549.72M | $405.27M |
Volume | 6,635,687 | 1,810,837 |
Sector | Industrials | Consumer Staples |
52-Week High | $13.19 | $43.68 |
52-Week Low | $2.50 | $8.28 |
Typical Hold Time | 11 Days | 14 Days |
Enterprise Value | $611.42M | $492.28M |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.55, down 5.56% on the day, reflecting a bearish technical outlook with significant selling pressure indicated by moving averages and oscillators. Fundamentally, the company is in a high-growth, pre-profitability phase, with revenue growing to $36 million in 2026 but net losses widening to -$170 million. Recent news is dominated by a sudden CEO resignation in August 2026, though the company reaffirmed its strategy and operational guidance.
The investment case hinges on the company's advanced battery technology and expansion plans, particularly in the defense and drone sectors, against a backdrop of persistent cash burn and high execution risk. Analyst consensus remains bullish with a $10.75 price target, but the stock faces near-term volatility from leadership uncertainty and the challenging path to profitability.
Vital Farms (VITL) trades at $9.24, down 1.7% on the day, reflecting ongoing pressure from weak earnings and industry headwinds. The stock shows a bearish technical trend with key support at $9.00, while fundamentals reveal a sharp decline in profitability with a net margin of just 0.02% in 2026. Recent news highlights strategic review discussions and institutional acquisitions, yet negative cash flow and pricing challenges in the egg market weigh on investor confidence.
The outlook remains cautious with significant execution risks amid industry oversupply, though analyst consensus suggests upside potential to a $13.11 price target. Investment opportunity hinges on a successful strategic review and margin recovery, but risks include sustained cash burn and competitive pressures that could limit near-term gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Vital Farms is a leading provider of ethically produced, pasture-raised eggs and butter in the United States. Operating as a Public Benefit Corporation, it manages a network of over 650 family farms to deliver high-welfare food products. It leverages a scalable 'asset-light' partnership model that prioritizes transparency and animal welfare to meet the growing consumer demand for clean-label and sustainable food sources.
Read more on VITL →